Knee osteoarthritis. Bilateral primary osteoarthritis of knee
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: From 36 years old and above Knee pain for more than 3 months, at least 3 on the VAS scale in activities such as going up and down stairs or sitting and squatting Diagnosis of knee osteoarthritis based on clinical criteria + ACR radiography Grade one or two on knee radiographs based on the Kellgren Lawrence system Ability to perform the desired exercises
Exclusion criteria
Exclusion criteria: Use of sedatives, narcotics, muscle relaxants, or other undefined analgesics within 2 weeks prior to the start of the study. Intra-articular steroid injection within 3 weeks or systemic steroid administration within 2 weeks prior to the start of the study. Platelet-rich plasma (PRP) injection within the past 6 months. Ozone therapy within the past 3 months. Intra-articular injection of hyaluronic acid gel within the past 6 months. Use of topical herbal treatments, thermal therapy, or acupuncture within 2 weeks prior to the start of the study. Presence of severe neuropathy or significant neuromuscular disease that prevents the patient from tolerating the intervention. Presence of knee pain due to causes other than osteoarthritis. Presence of an open wound on the knee surface. History of severe knee trauma or previous knee or lower limb surgery. History of malignancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| WOMAC questionnaire score. Timepoint: Before the start of the intervention, after 7 weeks of intervention, and at the end of week 11. Method of measurement: WOMAC questionnaire.;Pain. Timepoint: Before the start of the intervention, after 7 weeks of intervention, and at the end of week 11. Method of measurement: Visual Analysis Score(VAS).;Knee range of motion (ROM). Timepoint: Before the start of the intervention, after 7 weeks of intervention, and at the end of week 11. Method of measurement: Goniometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life. Timepoint: Before the start of the intervention, after 7 weeks of intervention, and at the end of week 11. Method of measurement: Quality of Life Questionnaire(SF12).;Diclofenac consumption. Timepoint: Before the start of the intervention, after 7 weeks of intervention, and at the end of week 11. Method of measurement: Patient self-report. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahed University